Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Human Aquaporin-4 and Molecular Modeling: Historical Perspective and View to the Future.
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
Cognitive performance, fatigue and event-related potentials in patients with clinically isolated syndrome.
Special Issue: Myelin Repair.
Fitness and its association with fatigue in persons with multiple sclerosis.
Clinical Utility of Mindfulness Training in the Treatment of Fatigue After Stroke, Traumatic Brain Injury and Multiple Sclerosis: A Systematic Literature Review and Meta-analysis.
Role of IL-33 and ST2 signalling pathway in multiple sclerosis: expression by oligodendrocytes and inhibition of myelination in central nervous system.
Does early (treatment in) BENEFIT lead to late MS benefit?
Identification of gene expression patterns critically involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
Cuprizone demyelination induces a unique inflammatory response in the subventricular zone.
Guillain-Barré syndrome: What have we learnt during one century? A personal historical perspective.
Clinical Application of Autologous Adipose Stem Cells in Patients with Multiple Sclerosis: Preliminary Results.
The Gas6/TAM System and Multiple Sclerosis.
IL-27 plasma level in relapsing remitting multiple sclerosis subjects: The double-faced cytokine.
Erratum to: 'Purkinje cell injury, structural plasticity and fusion in patients with Friedreich's ataxia'.
Network of nuclear receptor ligands in multiple sclerosis: Common pathways and interactions of sex-steroids, corticosteroids and vitamin D3-derived molecules.
Etiological, clinical, and radiological features of longitudinally extensive myelopathy in Chinese patients.
A rapid and versatile method for the isolation, purification and cryogenic storage of Schwann cells from adult rodent nerves.
Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus conference on Pain in Neurorehabilitation.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in the province of Alicante].
In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis.
A decade of natalizumab and PML: Has there been a tacit transfer of risk acceptance?
Multiple Sclerosis and Obesity: Possible Roles of Adipokines.
Foxo3 Transcription Factor Drives Pathogenic T Helper 1 Differentiation by Inducing the Expression of Eomes.
Pure alexia in a patient with multiple sclerosis.
Pages
« first
‹ previous
…
791
792
793
794
795
796
797
798
799
…
next ›
last »